ARVO 2025 presentation: Comparison of blue light-induced damage (BLD) in albino and pigmented mice
This study aimed at comparing blue light-induced retinal injury in albino Balb/cJRj and pigmented C57BL/6JRj mice.
Learn more
ARVO 2025 presentation: Triamcinolone delays retinal atrophy in a mouse laser-induced geographic atrophy model
Limited treatment options for patients with geographic atrophy (GA) pose challenges to find proper positive controls in preclinical models. This study aimed to test the efficacy of subconjunctival administration of triamcinolone in a laser-induced mouse model of GA.
Learn more
ARVO 2025 presentation: Human cornea-on-a-chip – opportunities and challenges
Cornea is a tight barrier restricting topically administered drugs’ penetration into the eye. The aim of the study was to create a tight epithelial barrier both with primary and with transformed human corneal cells on a 96-well microfluidic platform.
Learn more
The 8th Gene Therapy Summit in Boston – let’s connect!
Experimentica is attending to the 8th Gene Therapy Summit in Boston on March 25-27, 2025. Reach out to schedule a meeting with us!
Learn more
Experimentica is heading to BIO-Europe Spring 2025 in Milan
Come to meet us in BIO-Europe Spring 2025 in Milan! Our Executive Chairman Giedrius Kalesnykas and CBO Guillaume Demarne are attending the event on March 17-19, 2025.
Learn more
Experimentica UAB (Lithuania) receives full accreditation from AAALAC International
Experimentica UAB in Lithuania achieved a major accomplishment by receiving a full accreditation from AAALAC International for its outstanding work on animal welfare.
Learn more
Experimentica Oy Announces Appointment of New Managing Director
Experimentica Oy announces the appointment of a new Managing Director. The current CEO will transition to the role of Executive Chairman.
Learn more
Meet Us at Bio-Europe 2024!
Experimentica will be presenting preclinical ocular models at Bio-Europe 2024 in Stockholm, Nov. 4-6, 2024.
Learn more
Kon’nichiwa BioJapan 2024!
Experimentica will be presenting preclinical ocular models at BioJapan 2024 in Yokohama, Oct. 9-11, 2024.
Learn more
Meet Experimentica at the 5th Gene Therapy for Ophthalmic Disorders Summit in Boston
Experimentica attends the 5th Gene Therapy for Ophthalmic Disorders Summit in Boston, Sept. 10-12, 2024.
Learn more
